Discovery of decreased ferroptosis in male colorectal cancer patients with KRAS mutations is a research paper published in Redox Biology (2023). On theSindex it has a DataRank of 0.550. It has been cited 38 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.550
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: K12CA215110
National Cancer Institute
Grant: F30CA254246
National Cancer Institute
Grant: 5P50CA121974
National Cancer Institute
Grant: UL1 TR001863
American Cancer Society
Grant: 134273-RSG-20-065-01-TBE
NCI NIH HHS
Grant: R21 CA223686
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: T32 CA250803
NCI NIH HHS
Grant: P50 CA121974
National Institutes of Health
Grant: 1K12CA215110-01A1
The Yale Cancer Center Calabresi Immuno-Oncology Training Program (IOTP)
National Institutes of Health
Grant: 3UL1TR001863-08S1
Yale Clinical and Translational Science Award: Nwanaji-Enwerem Diversity in Health Related Research
National Institutes of Health
Grant: 5F30CA254246-02
Ferroptosis as a Modulator of Checkpoint Inhibitor Immunotherapy
National Institutes of Health
Grant: 2P50CA121974-06A1
The RAC1 Pathway as aTarget for Melanoma Therapy
National Institutes of Health
Grant: 5R21CA223686-02
Understanding sex differences in colon cancer metabolism
NIH
National Center for Advancing Translational Sciences
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals